Showing 1781-1790 of 5771 results for "".
- Novartis Announces Positive Year 2 Results of Phase 3 KESTREL Study of Beovu in Diabetic Macular Edemahttps://modernod.com/news/novartis-announces-positive-results-from-year-2-of-the-phase-3-trial-of-beovu-in-diabetic-macular-edema/2480504/Novartis announced the first interpretable results from year 2 (week 100) of the phase 3 KESTREL study. KESTREL assessed the safety and efficacy of Beovu (brolucizumab) 6 mg in patients with visual impairment due to diabetic macular edema (DME). Results from year 2 confirmed the visual acuit
- Ocular Therapeutix Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Diseasehttps://modernod.com/news/ocular-therapeutix-announces-topline-results-for-phase-2-clinical-trial-of-otx-ded-for-the-short-term-treatment-of-dry-eye-disease/2480496/Ocular Therapeutix announced positive topline results from its phase 2 clinical trial of OTX-DED (dexamethasone intracanalicular ophthalmic insert) for the short-term treatment of dry eye disease. The phase 2 clinical trial is a US-based, randomized, double-masked, vehicle-controlled, m
- GenSight Biologics Announces Publication of Non-Human Primate Study Reporting Presence of Lumevoq Vector DNA in Contralateral Eyes After Unilateral Injectionhttps://modernod.com/news/gensight-biologics-announces-publication-of-non-human-primate-study-reporting-presence-of-lumevoq-vector-dna-in-contralateral-eyes-after-unilateral-injection/2480491/GenSight Biologics announced that the journal "Molecular Therapy – Methods and Clinical Development" has published the results of a mechanistic study demonstrating the transfer of Lumevoq vector DNA from the injected eyes to the non-injected eyes of non-human prim
- CoFi Announces 300 Eye Care Practices Now Use CoFi’s Compliant Co-Management Payments Tool for Ophthalmology Procedureshttps://modernod.com/news/cofi-announces-300-eye-care-practices-now-use-cofis-compliant-co-management-payments-tool-for-ophthalmology-procedures/2480490/CoFi, a provider of a multi-party payments platform for elective medical procedures, announced the growing adoption of its co-management payment solution for ophthalmology procedures with more than 300 practices now using CoFi. Throughout ophthalmology, there i
- Kubota Vision Announces Publication in Scientific Reports of Study Data for Wearable Myopia-Control Devicehttps://modernod.com/news/kubota-vision-announces-publication-in-scientific-reports-of-study-data-for-wearable-myopia-control-device/2480478/Kubota Vision announced the publication of a new paper in the journal Scientific Reports: Effect of short-term peripheral myopic defocus on ocular biometrics using Fresnel “press-on” lenses in humans. The paper
- CooperCompanies Announces Executive Management Changeshttps://modernod.com/news/coopercompanies-announces-executive-management-changes/2480477/CooperCompanies announced two senior leadership changes that will enable the company to maximize current and future opportunities. Effective February 1, 2022, Dan McBride, Executive Vice President (EVP), Chief Operating Off
- Ocuphire Announces Enrollment of First Patients in Second Phase 3 Pivotal Trial (MIRA-3) for Nyxol in Reversal of Mydriasishttps://modernod.com/news/ocuphire-announces-enrollment-of-first-patients-in-second-phase-3-pivotal-trial-mira-3-for-nyxol-in-reversal-of-mydriasis-rm/2480472/Ocuphire Pharma announced that the first subjects have been enrolled in the MIRA-3 phase 3 pivot
- Evoq Technologies Announces Launch of First Smartphone-Based Product for Retinal Health Testinghttps://modernod.com/news/evoq-technologies-llc-announces-launch-of-first-smartphone-based-product-for-retinal-health-testing/2480471/Evoq Technologies has announced the FDA registration of the first in its family of products based on its proprietary smartphone-based biosensor technology. Dubbed the ‘SmartERG’ platform, it’s built t
- Euclid Systems Names Key Leadership Hires and Announces Major Facility Expansionhttps://modernod.com/news/euclid-systems-names-key-leadership-hires-and-announces-major-facility-expansion/2480465/Euclid Systems announced two additions to its leadership team as well as the expansion of its manufacturing facility in Sterling, Virginia. The changes come at a time when Euclid’s next-gene
- Eyenuk Announces Publication of Strong EyeArt Pivotal Clinical Trial Results in JAMA Network Openhttps://modernod.com/news/eyenuk-announces-publication-of-strong-eyeart-pivotal-clinical-trial-results-in-jama-network-open/2480451/Eyenuk announced that strong results from the EyeArt prospective, multicenter pivotal clinical trial were published as an original investigation in JAMA Network Open, a peer-reviewed medical journal published by the American Medical Association. The artic